PNV-DHA
Active substance: ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, PYRIDOXINE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM, FERROUS FUMARATE, MAGNESIUM, DOCONEXENT
CAPSULE, GELATIN COATED · ASCORBIC ACID 85 [iU]/1, CHOLECALCIFEROL 200 [iU]/1, .ALPHA.-TOCOPHEROL ACETATE, DL- 10 [iU]/1, PYRIDOXINE 25 [iU]/1, FOLIC ACID 1 mg/1, CYANOCOBALAMIN 12 ug/1, CALCIUM 140 mg/1, FERROUS FUMARATE 27 mg/1, MAGNESIUM 45 mg/1, DOCONEXENT 300 mg/1
United StatesActive
Marketing holder: Acella Pharmaceuticals, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- ASCORBIC ACID · 85 [iU]/1
- CHOLECALCIFEROL · 200 [iU]/1
- .ALPHA.-TOCOPHEROL ACETATE, DL- · 10 [iU]/1
- PYRIDOXINE · 25 [iU]/1
- FOLIC ACID · 1 mg/1
- CYANOCOBALAMIN · 12 ug/1
- CALCIUM · 140 mg/1
- FERROUS FUMARATE · 27 mg/1
- MAGNESIUM · 45 mg/1
- DOCONEXENT · 300 mg/1
Registration
- Registration number
- 42192-321
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 42192-321 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 42192-321 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 42192-321 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 42192-321 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 42192-321 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 42192-321 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 42192-321 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 42192-321 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 42192-321 · Verified 2026-10-09 · open in source
- ingredients.7 · openFDA NDC · 42192-321 · Verified 2026-10-09 · open in source
- ingredients.8 · openFDA NDC · 42192-321 · Verified 2026-10-09 · open in source
- ingredients.9 · openFDA NDC · 42192-321 · Verified 2026-10-09 · open in source